Development of high throughput screening assays using fluorescence polarization: Nuclear receptor-ligand-binding and kinase/phosphatase assays

Journal of Biomolecular Screening

Volumn 5, Issue 2, 2000, Pages 77-88

  Parker, Gregory J ^a   Law, Tong Lin ^a   Lenoch, Francis J ^a   Bolger, Randall E ^a  

^a INVITROGEN CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; ESTROGEN RECEPTOR; PHOSPHOTRANSFERASE;

ARTICLE; BINDING AFFINITY; DEPHOSPHORYLATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; FLUORESCENCE; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; LIGAND BINDING; POLARIZATION; PRIORITY JOURNAL;

EID: 0008190079     PISSN: 10870571     EISSN: None     Source Type: Journal    
DOI: 10.1177/108705710000500204     Document Type: Article

References (35)

1. Drews, J. (1996). Genomic sciences and the medicine of tomorrow. Nat. Biotechnol. 14:1516-1517.
2. Gallop, M.A., Barrett, R.W., Dower, W.J., Fodor, S.P., Gordon, E.M. (1994). Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries. J. Med. Chem. 37:1233-1251.
3. Pope, A.J., Haupts, U.M., Moore, K.J. (1999). Homogeneous fluorescence readouts for miniaturized high-throughput screening: Theory and practice. Drug Discov. Today 4:350-362.
4. Heyduk, T., Ma, Y., Tand, H., Ebright, R.H. (1996). Fluorescence anisotropy: Rapid, quantitative assay for protein-DNA and protein-protein interaction. Methods Enzymol. 274:492-503.
5. Jameson, D.M., Sawyer, W.H. (1995). Fluorescence anisotropy applied to biomolecular interactions. Methods Enzymol. 246: 283-300.
6. Checovich, W.J., Bolger, R.E., Burke, T. (1995). Fluorescence polarization - a new tool for cell and molecular biology. Nature 375:254-256.
7. Bolger, R., Wiese, T.E., Ervin, K., Nestich, S., Checovich, W. (1998). Rapid screening of environmental chemicals for estrogen receptor binding capacity. Environ. Health Perspect. 106: 551-557.
8. Lundblad, J.R., Laurance, M., Goodman, R.H. (1996). Fluorescence polarization analysis of protein-DNA and protein-protein interactions. Mol. Endocrinol. 10:607-612.
9. Ozers, M.S., Hill, J.J., Ervin, K., Wood, J.R., Nardulli, A.M., Royer, C.A. Gorski, J. (1997). Equilibrium binding of estrogen receptor with DNA using fluorescence anisotropy. J. Biol. Chem. 272:30405-30411.
10. Wu, P., Brasseur, M., Schindler, W. (1997). A high-throughput STAT binding assay using fluorescence polarization. Anal. Biochem. 249:29-36.
11. Bolger, R., Checovich, W. (1994). A new protease activity assay using fluorescence polarization. Biotechniques 17:585-589.
12. Bolger, R., Thompson, D. (1994). A quantitative RNase assay using fluorescence polarization. Am. Biotechnol. Lab. 12:113-116.
13. Turner, R.T., Riggs, B.L., Spelsberg, T.C. (1994). Skeletal effects of estrogen. Endocr. Rev. 15:275-300.
14. Ciocca, D.R., Roig, L.M. (1995). Estrogen receptors in human nontarget tissues: Biological and clinical implications. Endocr. Rev. 16:35-61.
15. Farhat, M.Y., Lavigne, M.C., Ramwell, P.W. (1996). The vascular protective effects of estrogen. FASEB J. 10:615-624.
16. Kuiper, G.G.J.M., Enmark, E., Pelto-Huikko, M., Nilsson, S., Gustadsson, J.-A. (1996). Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U.S.A. 93:5925-5930.
17. Nilsson, S., Kuiper, G., Gustafsson, J.-A. (1998). ERβ: A novel estrogen receptor offers the potential for new drug development. Trends Endocrinol. Metab. 9:387-395.
18. Korach, K.S., McLachlan, J.A. (1995). Techniques for detection of estrogenicity. Environ. Health Perspect. 103:5-8.
19. Soto, A.M., Sonnenschein, C., Chung, K.L., Fernandez, M.F., Olea, N., Serrano, F.O. (1995). The E-SCREEN assay as a tool to identify estrogens: An update on estrogenic environmental pollutants. Environ. Health Perspect. 7:113-122.
20. Reese, J.C., Katzenellenbogen, B.S. (1991). Mutagenesis of cysteines in the hormone binding domain of the human estrogen receptor: Alterations in binding and transcriptional activation by covalently and reversibly attaching ligands. J. Biol. Chem. 266:10880-10887.
21. 3H]estradiol binding constants for hER-HBD. Biotechniques 18:146-151.
22. Hunter, T. (1995). Protein kinases and phosphatases: The yin and yang of protein phosphorylation and signaling. Cell 80:225-236.
23. Hunter, T. (1998). The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: Its role in cell growth and disease. Philos. Trans. R. Soc. Land. B Biol. Sci. 353:583-605.
24. Pawson, T. (1995). Protein modules and signalling networks. Nature 373:573-580.
25. von Deimling, A., Louis, D.N., Wiestler, O.D. (1995). Molecular pathways in the formation of gliomas. Glia 15:328-338.
26. Friess, H., Berberat, P., Schilling, M., Kunz, J., Korc, M., Buchler, M.W. (1996). Pancreatic cancer: The potential clinical relevance of alterations in growth factors and their receptors. J. Mol. Med. 74:35-42.
27. Wong, A.J., Ruppert, J.M., Bigner, S.H., Grzeschik, C.H., Humphrey, P.A., Bigner, D.S., Vogelstein, B. (1992). Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc. Natl. Acad. Sci. U.S.A. 89:2965-2969.
28. Eppstein, D.A., Marsh, Y.V., Schryver, B.B., Bertics, P.J. (1989). Inhibition of epidermal growth factor/transforming growth factor-alpha-stimulated cell growth by a synthetic peptide. J. Cell. Physiol. 141:420-430.
29. 33phosphorus. Anal. Biochem. 237:129-134.
30. Kolb, A.J., Kaplita, P.V., Hayes, D.J., Park, Y.-W., Pernell, C., Major, J.S., Mathis, G. (1998). Tyrosine kinase assays adapted to homogeneous time-resolved fluorescence. Drug Discov. Today 3:333-342.
31. Nishizuka, Y. (1986). Studies and perspectives of protein kinase C. Science 233:305-312.
32. Nishizuka, Y. (1992). Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-614.
33. Dekker, L.V., Parker, P.J. (1994). Protein kinase C - a question of specificity. Trends Biochem. Sci. 19:73-77.
34. Hu, H. (1996). Recent discovery and development of selective protein kinase C inhibitors. Drug Discov. Today 1:438-447.
35. ++ dependent protein kinase. Biochem. Biophys. Res. Commun. 135:397-402.